
Neurology
IV Fosphenytoin for Acute Trigeminal Neuralgia: What the Phase 3 Trial Means for Rescue Care
A multicenter phase 3 trial supports intravenous fosphenytoin for rapid relief during severe trigeminal neuralgia attacks. Its monitored administration and off-label US status limit where it can be used.
Dr. Abu Bakar · September 13, 2026 · 6 min
